Formulation of the company products and modification on the existing ones along with the preparation of 35-40 new dosage forms within the wrrent and upcoming  year are among major activities of the company’s R & D department.

Also, in cooperation with medical universities, due studies performed in order to evaluate the relative Bioavalability  and Bioequivalency  of the Pars Darou products in comparison with a standard formulation, using Iranian healthy volunteers.

Research & Development